1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. PATIENT POSITIONING SYSTEMS MARKET BY PRODUCT
5.1. Introduction
5.2. Tables
5.3. Accessories
5.4. Others
6. PATIENT POSITIONING SYSTEMS MARKET BY APPLICATION
6.1. Introduction
6.2. Surgery
6.3. Disease Diagnosis
6.4. Cancer Therapy
7. PATIENT POSITIONING SYSTEMS MARKET BY END-USER
7.1. Introduction
7.2. Hospitals and Clinics
7.3. Ambulatory Surgical Centers (ASCs)
7.4. Diagnostic Laboratories
7.5. Others
8. PATIENT POSITIONING SYSTEMS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Drug Class
8.2.2. By Indication
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Drug Class
8.3.2. By Indication
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Drug Class
8.4.2. By Indication
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Drug Class
8.5.2. By Indication
8.5.3. By End-User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. By Drug Class
8.6.2. By Indication
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. China
8.6.4.2. Japan
8.6.4.3. India
8.6.4.4. South Korea
8.6.4.5. Taiwan
8.6.4.6. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Stryker
10.2. Integra LifeSciences
10.3. Globus Medical
10.4. Qfix
10.5. Xodus Medical
10.6. Ergotrics
10.7. Cemar Electro
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES